(Q34798727)

4 August 2017

1 reference

title

Local treatment of brain tumors with targeted chimera cytotoxic proteins (English)

1 reference

4 August 2017

0 references

1 reference

Waldemar Debinski

1

1 reference

4 August 2017

publication date

1 January 2002

1 reference

4 August 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Cancer Investigation

1 reference

4 August 2017

volume

20

1 reference

4 August 2017

issue

5-6

1 reference

4 August 2017

page(s)

801-809

1 reference

Histopathology, classification, and grading of gliomas

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Characterization of the tumor invasion area in the rat intracerebral glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Structure, function, and clinical significance of human tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Monoclonal antibody C242-Pseudomonas exotoxin A. A specific and potent immunotoxin with antitumor activity on a human colon cancer xenograft in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Substitution of foreign protein sequences into a chimeric toxin composed of transforming growth factor alpha and Pseudomonas exotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Recombinant toxins as novel therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Modulation of molecular mechanisms involved in protein synthesis machinery as a new tool for the control of cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Redesigning nature's poisons to create anti-tumor reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Receptor for interleukin (IL) 13 does not interact with IL4 but receptor for IL4 interacts with IL13 on human glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Role of caspases in immunotoxin-induced apoptosis of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin,

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Brain drug delivery of small molecules using immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Capillary Ultrastructure and the Blood-Brain Barrier in Human Malignant Brain Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Intratumoral infusion of the monoclonal antibody, mAb 425, against the epidermal-growth-factor receptor in patients with advanced malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

The distribution of transferrin immunoreactivity in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Transferrin receptors in rat brain: neuropeptide-like pattern and relationship to iron distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Expression of a restrictive receptor for interleukin 13 is associated with glial transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Novel way to increase targeting specificity to a human glioblastoma-associated receptor for interleukin 13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

An immunotoxin with increased activity and homogeneity produced by reducing the number of lysine residues in recombinant Pseudomonas exotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Novel anti-brain tumor cytotoxins specific for cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Chromosome mapping and expression of the human interleukin-13 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Selective destruction of target cells by diphtheria toxin conjugated to antibody directed against antigens on the cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Treatment of advanced solid tumors with immunotoxin LMB-1: an antibody linked to Pseudomonas exotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

Effects of needle insertion in tumors on interstitial fluid pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120003545

21 January 2018

Identifiers

DOI

10.1081/CNV-120003545

1 reference

4 August 2017

1 reference